Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 2
2006 2
2007 2
2008 3
2009 4
2011 4
2012 4
2013 3
2014 4
2015 4
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Interferon therapy for chronic hepatitis B.
Asselah T, Lada O, Moucari R, Martinot M, Boyer N, Marcellin P. Asselah T, et al. Among authors: lada o. Clin Liver Dis. 2007 Nov;11(4):839-49, viii. doi: 10.1016/j.cld.2007.08.010. Clin Liver Dis. 2007. PMID: 17981231 Review.
[Treatment of chronic hepatitis B].
Asselah T, Lada O, Boyer N, Martinot M, Marcellin P. Asselah T, et al. Among authors: lada o. Gastroenterol Clin Biol. 2008 Aug-Sep;32(8-9):749-68. doi: 10.1016/j.gcb.2008.07.001. Epub 2008 Sep 4. Gastroenterol Clin Biol. 2008. PMID: 18775613 Free article. Review. French.
[Treatment of chronic hepatitis B].
Asselah T, Lada O, Marcellin P. Asselah T, et al. Among authors: lada o. Rev Prat. 2011 Jan;61(1):45-51. Rev Prat. 2011. PMID: 21452542 French.
Naturally Occurring Resistance-Associated Variants of Hepatitis C Virus Protease Inhibitors in Poor Responders to Pegylated Interferon-Ribavirin.
Larrat S, Vallet S, David-Tchouda S, Caporossi A, Margier J, Ramière C, Scholtes C, Haïm-Boukobza S, Roque-Afonso AM, Besse B, André-Garnier E, Mohamed S, Halfon P, Pivert A, LeGuillou-Guillemette H, Abravanel F, Guivarch M, Mackiewicz V, Lada O, Mourez T, Plantier JC, Baazia Y, Alain S, Hantz S, Thibault V, Gaudy-Graffin C, Bouvet D, Mirand A, Henquell C, Gozlan J, Lagathu G, Pronier C, Velay A, Schvoerer E, Trimoulet P, Fleury H, Bouvier-Alias M, Brochot E, Duverlie G, Maylin S, Gouriou S, Pawlotsky JM, Morand P. Larrat S, et al. Among authors: lada o. J Clin Microbiol. 2015 Jul;53(7):2195-202. doi: 10.1128/JCM.03633-14. Epub 2015 Apr 29. J Clin Microbiol. 2015. PMID: 25926499 Free PMC article.
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy.
Laouénan C, Guedj J, Peytavin G, Nguyen TT, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Marcellin P, Mentré F. Laouénan C, et al. Among authors: lada o. CPT Pharmacometrics Syst Pharmacol. 2015 Jan;4(1):e00008. doi: 10.1002/psp4.8. Epub 2014 Dec 30. CPT Pharmacometrics Syst Pharmacol. 2015. PMID: 26225222 Free PMC article.
Clinically relevant genotype interpretation of resistance to didanosine.
Marcelin AG, Flandre P, Pavie J, Schmidely N, Wirden M, Lada O, Chiche D, Molina JM, Calvez V; AI454-176 Jaguar Study Team. Marcelin AG, et al. Among authors: lada o. Antimicrob Agents Chemother. 2005 May;49(5):1739-44. doi: 10.1128/AAC.49.5.1739-1744.2005. Antimicrob Agents Chemother. 2005. PMID: 15855490 Free PMC article. Clinical Trial.
28 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page